한글목차

세계 파마 4.0 시장은 2025년에 168억 1,000만 달러로 추정되며, 2032년에는 551억 6,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 18.5%의 CAGR로 성장할 것으로 예상됩니다.

그림. 파마 4.0 세계 시장 점유율(%), 지역별, 2025년

파마 4.0은 인더스트리 4.0의 원칙에 따른 제약 산업의 변화를 의미합니다. 인더스트리 4.0은 사물인터넷(IoT), 인공지능(AI), 빅데이터 분석, 클라우드 컴퓨팅, 사이버 물리 시스템 등 첨단 기술을 제조 공정에 통합하는 것을 특징으로 합니다. 제약 산업의 맥락에서 이는 의약품 개발, 제조, 공급망 관리, 전반적인 업무 효율성 향상으로 이어집니다. 파마 4.0은 제약 업계의 4차 산업혁명으로 사물인터넷(IoT), 빅데이터 분석, 인공지능(AI), 머신러닝 등 첨단 기술의 통합을 특징으로 합니다. 이러한 기술들은 연구개발, 임상시험, 생산에 이르기까지 의약품 가치사슬의 다양한 측면에 혁명을 일으키고 있습니다. 또한, 제약사들이 혁신적인 표적 치료제와 정밀의료를 개발할 수 있도록 지원함으로써 맞춤형 의료를 가능하게 하고 있습니다. 세계 파마 4.0 시장은 비용 최소화, 생산성 향상, 경쟁 우위 확보를 위해 주요 기업들이 이러한 신흥 기술을 채택하는 경향이 강화됨에 따라 향후 몇 년 동안 크게 성장할 것으로 예상됩니다.

시장 역학:

세계 파마 4.0 시장은 신약개발 및 시장개척 프로세스 개선에 대한 니즈 증가, 맞춤형 의약품에 대한 수요 증가, 제조 업무의 디지털화에 대한 관심 증가, 공급망 가시성 및 효율성 향상을 위한 제약사의 노력 등 여러 요인에 의해 주도되고 있습니다. 그러나 새로운 기술 도입에 필요한 높은 투자 비용, 보안 침해 및 사이버 공격의 위험은 시장 성장에 걸림돌이 되고 있습니다. 파마 4.0은 데이터 기반 R&D, 임상시험 및 공급망 혼란에 대한 예측 분석, 새로운 디지털 치료법 개발, 맞춤형 의약품 제조를 위한 3D 프린팅 채택 등을 가능하게함으로써 큰 기회를 제공하고 있습니다. 주요 기업들은 이러한 기회를 활용하기 위해 신제품 출시와 파트너십에 집중하고 있습니다.

본 조사의 주요 특징

• 세계의 파마 4.0 시장에 대해 조사분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 파마 4.0 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 파마 4.0 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 세계 파마 4.0 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이해관계자들은 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 제품 발매 증가
  • 데이터 보안과 프라이버시에 관한 우려
  • 인공지능과 분석의 진보
• 주요 하이라이트
• 규제 시나리오
• 시장 동향
• PEST 분석
• PORTER의 분석
• 제품 발매
• 기술의 진보
• 합병, 인수 및 제휴

제4장 세계의 파마 4.0 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 파마 4.0 시장, 구성요소별, 2020-2032년

• 하드웨어
• 소프트웨어
• 서비스

제6장 세계의 파마 4.0 시장, 기술별, 2020-2032년

• 클라우드 컴퓨팅
• 인공지능
• 빅데이터 분석
• 사물인터넷

제7장 세계의 파마 4.0시장, 용도별, 2020-2032년

• 연구개발
• 제조업
• 공급망 관리
• 기타

제8장 세계의 파마 4.0 시장, 최종사용자별, 2020-2032년

• 바이오의약품 기업
• 수탁제조기관
• 수탁연구기관

제9장 세계의 파마 4.0 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제10장 경쟁 구도

• 기업 개요
  • Oracle
  • GE Healthcare
  • Optum, Inc.
  • Honeywell International Inc.
  • IBM Corporation
  • Cisco Systems, Inc
  • Siemens Healthcare GmbH
  • POLARISqb
  • Google Cloud
  • Optibrium
  • Syntekabio
  • Fujitsu Limited
  • SAS Health
  • Microsoft
  • Lotte Healthcare

제11장 섹션

• 참고문헌
• 조사 방법
• 출판사 소개

영문목차

Global Pharma 4.0 Market is estimated to be valued at USD 16.81 Bn in 2025 and is expected to reach USD 55.16 Bn by 2032, growing at a compound annual growth rate (CAGR) of 18.5% from 2025 to 2032.

Figure. Global Pharma 4.0 Market Share (%), By Region 2025

The term Pharma 4.0 refers to the transformation in the pharmaceutical industry that is aligned with the principles of Industry 4.0. Industry 4.0 is characterized by the integration of advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), big data analytics, cloud computing, and cyber-physical systems into manufacturing processes. In the context of the pharmaceutical industry, this translates to improvements in drug development, manufacturing, supply chain management, and overall operational efficiency. Pharma 4.0 refers to the fourth industrial revolution in the pharmaceutical industry, characterized by the integration of advanced technologies like the Internet of Things (IoT), big data analytics, artificial intelligence (AI), and machine learning. These technologies are revolutionizing various aspects of the pharmaceutical value chain from research and development, clinical trials, production. They are also enabling personalized healthcare by helping pharma companies develop innovative targeted therapies and precision medicine. The global pharma 4.0 market is projected to grow significantly in the coming years as major players are increasingly adopting these emerging technologies to minimize costs, enhance productivity, and gain a competitive edge.

Market Dynamics:

The global pharma 4.0 market is driven by several factors, such as the growing need to improve drug discovery and development processes, rising demand for personalized medicines, an increasing focus on digitalizing manufacturing operations, and the aims of pharmaceutical companies to enhance supply chain visibility and efficiency. However, the high investment costs required for the implementation of emerging technologies, the risks of security breaches, and cyberattacks pose challenges to market growth. Pharma 4.0 offers huge opportunities by enabling data-driven research and development, predictive analytics for clinical trials and supply chain disruptions, the development of new digital therapies, and the adoption of 3D printing for customized drug manufacturing. Key players are focusing on new product launches and partnerships to capitalize on these opportunities.

Key features of the study:

• This report provides in-depth analysis of the global pharma 4.0 market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pharma 4.0 market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study Oracle,GE Healthcare, Optum, Inc., Honeywell International Inc., IBM Corporation, Cisco Systems, Inc., Siemens Healthcare GmbH, POLARISqb, Google Cloud, Optibrium, Syntekabio, Fujitsu Limited, SAS Health, Microsoft and Lotte Healthcare
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global pharma 4.0 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharma 4.0 market

Detailed Segmentation:

• Global Pharma 4.0 Market, By Component
  • Hardware
  • Software
  • Services
• Global Pharma 4.0 Market, By Technology
  • Cloud Computing
  • Artificial Intelligence
  • Big Data Analytics
  • Internet of Things
• Global Pharma 4.0 Market, By Application
  • Research and Development
  • Manufacturing
  • Supply Chain Management
  • Others
• Global Pharma 4.0 Market, By End User
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
• Global Pharma 4.0 Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Oracle
  • GE Healthcare
  • Optum, Inc.
  • Honeywell International Inc.
  • IBM Corporation
  • Cisco Systems, Inc.
  • Siemens Healthcare GmbH
  • POLARISqb
  • Google Cloud
  • Optibrium
  • Syntekabio
  • Fujitsu Limited
  • SAS Health
  • Microsoft
  • Lotte Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Component
  • Market Snippet, By Technology
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing Product Launch
  • Data Security and Privacy Concerns
  • Advancements in Artificial Intelligence and Analytics
• Key Highlights
• Regulatory Scenario
• Market Trends
• PEST Analysis
• PORTER's Analysis
• Product Launches
• Technological Advancements
• Mergers, Acquisitions, and Collaborations

4. Global Pharma 4.0 Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Pharma 4.0 Market, By Component, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hardware
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Pharma 4.0 Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cloud Computing,
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Artificial Intelligence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Big Data Analytics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Internet of Things
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Pharma 4.0 Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Research and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Manufacturing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Supply Chain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Pharma 4.0 Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Manufacturing Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Pharma 4.0 Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Oracle
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • GE Healthcare
  • Optum, Inc.
  • Honeywell International Inc.
  • IBM Corporation
  • Cisco Systems, Inc
  • Siemens Healthcare GmbH
  • POLARISqb
  • Google Cloud
  • Optibrium
  • Syntekabio
  • Fujitsu Limited
  • SAS Health
  • Microsoft
  • Lotte Healthcare
• Analyst Views

11. Section

• References
• Research Methodology
• About us